su 4984 has been researched along with su 5402 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirth, P; Hubbard, SR; McMahon, G; Mohammadi, M; Schlessinger, J; Sun, L; Tang, C; Yeh, BK | 1 |
| App, H; Hirth, P; McMahon, G; Sun, L; Tang, C; Tang, F; Tran, N | 1 |
| Coutinho, EC; Jaggi, M; Karia, D; Loriya, R; Manvar, A; Mukherjee, R; Shah, A; Shaikh, MS; Singh, A; Upadhyay, K; Virsodia, V | 1 |
| Cheng, W; Tian, X; Wang, M; Zhang, X | 1 |
| Elbaum, D; Lydon, NB; Toledo, LM | 1 |
| Carter, E; Longley, BJ; Ma, Y; McMahon, G | 1 |
3 review(s) available for su 4984 and su 5402
| Article | Year |
|---|---|
An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors.
Topics: Humans; Protein Binding; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Small Molecule Libraries | 2017 |
The structure-based design of ATP-site directed protein kinase inhibitors.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship | 1999 |
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.
Topics: Amino Acid Substitution; Combined Modality Therapy; Drug Design; Enzyme Activation; Enzyme Inhibitors; Feasibility Studies; Humans; Indoles; Ligands; Mast Cells; Mastocytosis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Pyrroles; Stem Cell Factor | 2000 |
3 other study(ies) available for su 4984 and su 5402
| Article | Year |
|---|---|
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.
Topics: 3T3 Cells; Adenosine Triphosphate; Amino Acid Sequence; Animals; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Hydrogen Bonding; Mice; Models, Molecular; Phosphorylation; Phosphotyrosine; Piperazines; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Insulin; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor | 1997 |
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
Topics: Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Magnetic Resonance Spectroscopy; Phosphorylation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Stereoisomerism; Structure-Activity Relationship | 1998 |
Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Indoles; Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared | 2009 |